Evidence map›Paper›PMID 32629737›Full record

Trial reportMedicine2020

Clinical research for whether the Traditional Chinese medicine could promote the resorption of lumbar disc herniation: a randomized controlled trial.

Jintao Liu, Yu Zhu, Zhiqiang Wang, Pengfei Yu, Chunchun Xue, Hong Jiang, Xiaofeng Li, Dezhi Tang

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Jintao LiuSuzhou Hospital of Traditional Chinese Medicine, Suzhou, Jiangsu.ORCID 0000-0002-0495-9775
Yu ZhuSuzhou Hospital of Traditional Chinese Medicine, Suzhou, Jiangsu.
Zhiqiang WangSuzhou Hospital of Traditional Chinese Medicine, Suzhou, Jiangsu.
Pengfei YuSuzhou Hospital of Traditional Chinese Medicine, Suzhou, Jiangsu.
Chunchun XueShanghai Traditional Chinese Medicine Hospital, PR China.
Hong JiangSuzhou Hospital of Traditional Chinese Medicine, Suzhou, Jiangsu.
Xiaofeng LiLonghua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai.
Dezhi TangLonghua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai.
Suzhou Traditional Chinese Medicine Hospital · CNShanghai University of Traditional Chinese Medicine · CNShanghai Traditional Chinese Medicine Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lumbar disc herniation (LDH) is a common, disabling musculoskeletal disorder. Magnetic resonance imaging has clarified the natural history of lumbar disc lesions and has documented that disc lesions can become smaller and can even be completely resorbed. Previous studies have confirmed that some traditional Chinese medicine (TCM) therapies can promote resorption of the protrusion. However, high-quality research evidence is needed to support the effectiveness of the protocol.

objectiveThis clinical trial aims to establish whether TCM can promote the resorption of LDH and to assess the efficacy of such therapy for LDH, thereby evaluating its clinical effect.

methodsThe present study design is for a single-center, 2-arm, open-label randomized controlled trial. A total of 150 eligible LDH patients will be randomly assigned to either a TCM treatment group or a control group in a 1:1 ratio. Patients in the TCM group will be administered a TCM decoction for 4 weeks. Patients in the conventional drug control group will be instructed to take a specific daily dose of celecoxib. The primary outcome measure is the change from baseline in the volume of the protrusion, as assessed using MR images. Secondary outcome measures include visual analog scale pain scores and Japanese Orthopaedic Association scores assessed at 3 and 6 months. DISCUSSION: The design and methodological rigor of this trial will allow evaluation of the basic clinical efficacy and safety data for TCM in the treatment of patients with LDH. The trial will also assess whether TCM can promote the resorption of LDH. This research will therefore help provide a solid foundation for the clinical treatment of LDH and for future research in TCM therapy.

trial registrationChiCTR1900022377.

Indexed as

AdultAnti-Inflammatory Agents, Non-SteroidalCase-Control StudiesCelecoxibHumansIntervertebral Disc DisplacementLumbar VertebraeMagnetic Resonance ImagingMedicine, Chinese TraditionalMiddle AgedPain MeasurementRemission, SpontaneousResearch DesignSafetyTreatment OutcomeVisual Analog ScaleAnti-Inflammatory Agents, Non-SteroidalCelecoxib

Identifiers

PMID32629737
PMCPMC7337462
OpenAlexW3040006366

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.